Regal Assets Analytics

Codiak (CDAK) to report early exoSTING data; SanaCurrents closing coverage

By |2021-11-09T10:11:51-05:00November 8th, 2021|Tags: |

When SanaCurrents issued a March 19 report forecasting a positive outcome for Codiak Biosciences’ (NASDAQ:CDAK) phase I/II exoSTING trial, the favorable outlook was based [...]

Clene’s (CLNN) lead drug shows promise in ALS but falls short on key endpoints; SanaCurrents closing coverage

By |2021-11-03T20:45:17-04:00November 2nd, 2021|Tags: |

On November 2, Clene, Inc. (NASDAQ:CLNN) reported its RESCUE-ALS phase II trial, testing the drug CNM-Au8, did not meet the [...]

Go to Top